Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 9 results.
User Information
Export Records
  1. 1.   Considerations for a Reliable In Vitro Model of Chemotherapy-Induced Peripheral Neuropathy
  2. Eldridge, Sandy; Scuteri, Arianna; Jones, Eugenia M. C.; Cavaletti, Guido; Guo, Liang; Glaze, Elizabeth
  3. Toxics. 2021, Nov 11; 9(11):
  1. 2.   Bimodal Imaging of Mouse Peripheral Nerves with Chlorin Tracers
  2. Gonzales, Junior; Hernandez-Gil, Javier; Wilson, Thomas C.; Adilbay, Dauren; Cornejo, Mike; de Souza Franca, Paula Demetrio; Guru, Navjot; Schroeder,Christina; King, Glenn F.; Lewis, Jason S.; Reiner, Thomas
  3. Molecular Pharmaceutics. 2021, Mar 1; 18(3): 940-951.
  1. 3.   A Comparative Review of Chemotherapy-Induced Peripheral Neuropathy in In Vivo and In Vitro Models
  2. Eldridge, Sandy; Guo,Liang; Hamre, John
  3. Toxicologic pathology. 2019, Jul 22;
  1. 4.   Behavioral and Molecular Exploration of the AR-CMT2A Mouse Model Lmna (R298C/R298C)
  2. Poitelon, Y.; Kozlov, S.; Devaux, J.; Vallat, J. M.; Jamon, M.; Roubertoux, P.; Rabarimeriarijaona, S.; Baudot, C.; Hamadouche, T.; Stewart, C. L.; Levy, N.; Delague, V.
  3. Neuromolecular Medicine. 2012, Mar; 14(1): 40-52.
  1. 5.   Novel Substrate-Based Inhibitors of Human Glutamate Carboxypeptidase II with Enhanced Lipophilicity
  2. Plechanovova, A.; Byun, Y.; Alquicer, G.; Skultetyova, L.; Mlcochova, P.; Nemcova, A.; Kim, H. J.; Navratil, M.; Mease, R.; Lubkowski, J.; Pomper, M.; Konvalinka, J.; Rulisek, L.; Barinka, C.
  3. Journal of Medicinal Chemistry. 2011, Nov; 54(21): 7535-7546.
  1. 6.   Mitochondrial Haplogroups Are Associated With Risk of Neuroretinal Disorder in HIV-Positive Patients
  2. Hendrickson, S. L.; Jabs, D. A.; Van Natta, M.; Lewis, R. A.; Wallace, D. C.; O'Brien, S. J.
  3. Jaids-Journal of Acquired Immune Deficiency Syndromes. 2010, Apr; 53(4): 451-455.
  1. 7.   The DNA binding and 3'-end preferential activity of human tyrosyl-DNA phosphodiesterase
  2. Dexheimer, T. S.; Stephen, A. G.; Fivash, M. J.; Fisher, R. J.; Pommier, Y.
  3. Nucleic Acids Research. 2010, Apr; 38(7): 2444-2452.
  1. 8.   Bioisosterism of urea-based GCPII inhibitors: Synthesis and structure-activity relationship studies
  2. Wang, H. F.; Byun, Y.; Barinka, C.; Pullambhatla, M.; Bhang, H. E. C.; Fox, J. J.; Lubkowski, J.; Mease, R. C.; Pomper, M. G.
  3. Bioorganic & Medicinal Chemistry Letters. 2010, Jan; 20(1): 392-397.
  1. 9.   4-Pregnen-21-ol-3,20-dione-21-(4-bromobenzenesufonate) (NSC 88915) and Related Novel Steroid Derivatives as Tyrosyl-DNA Phosphodiesterase (Tdp1) Inhibitors
  2. Dexheimer, T. S.; Gediya, L. K.; Stephen, A. G.; Weidlich, I.; Antony, S.; March, C.; Interthal, H.; Nicklaus, M.; Fisher, R. J.; Njar, V. C.; Pommier, Y.
  3. Journal of Medicinal Chemistry. 2009 52(22): 7122-7131.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel